Connect With a Global Community of 150+ Pulmonary Fibrosis Expert Decision Makers
With Boehringer’s Phase III success for nerandomilast, we are entering a new era for IPF drug development. After years of frustration and failed trials, this long-awaited momentum is reigniting hope and bringing a long-overdue vote of confidence to the field. It’s a pivotal moment, one that is energizing the global community and accelerating investment across discovery, translational, and clinical programs.
The appetite for innovation in progressive pulmonary fibrosis has never been greater. Drug developers worldwide are doubling down on fibrosis pipelines, and the demand for strategic, science-driven partnerships is rapidly rising. The 9th ΙPF Summit convenes a uniquely focused audience of R&D leaders and decision-makers actively seeking solutions to their most pressing challenges.
For almost a decade, the IPF Summit has been the trusted partner platform for service providers to elevate their brand, showcase technical expertise, and forge lasting relationships with the industry’s key players.
If you’re looking to capitalize on this infectious industry energy, join us to position your company at the forefront of this space, we will work with you to craft a bespoke package that aligns your brand with the opportunity in pulmonary fibrosis.
What to Expect?
Build High-Value Connections & Opportunities
Maximize your time with targeted networking formats designed to put you face-to-face with senior decision-makers. From speed networking to curated 1-on-1 introductions, expand your reach and generate meaningful business opportunities across the pulmonary fibrosis community.Â
Stand Out & Position Your Offering as Essential
Set yourself apart from the competition by showcasing how your solutions uniquely support drug developers, whether through advanced lung models, cutting-edge imaging platforms, or specialized clinical CRO services. Position your offering as the preferred choice for future partnerships.Â
Boost Recognition Among a Niche Audience
Place your brand front and centre before, during, and after the event with integrated marketing exposure. Capture the attention of leading innovators in IPF and solidify your company’s presence as a recognized and reliable force in the space.Â
Create Impact with a Hands-On Experience
Put your capabilities on display with an interactive booth space tailored to your brand. Offer prospective clients a first-hand look at your solutions and leave a strong, lasting impression of your role in advancing IPF therapeutic development.Â
Key Services & Solutions
Our attendees from respiratory focused biopharma are looking for service and solution providers with capabilities in the below areas but not limited to:Â
Preclinical Model Providers with Deep Understanding of Lung Fibrosis BiologyÂ
Providers developing next-generation in vivo and ex vivo platforms that closely emulate the lung microenvironment and disease trajectory to improve translatability from bench to bedsideÂ
Advanced Imaging & Diagnostic Tool Developers Supporting Early & Ongoing Disease InsightsÂ
Companies offering cutting-edge technologies, from imaging systems to digital screening solutions, that enable timely diagnosis, track disease evolution, and evaluate therapeutic outcomes and efficacyÂ
Comprehensive Biomarker Platform Partners from Discovery to DeploymentÂ
Partners offering robust biomarker development, spanning validated, minimally invasive, and exploratory markers, to support patient stratification, disease monitoring, and therapeutic responseÂ
Preclinical CROs with Expertise in Fibrosis Mechanisms & Early Target AssessmentÂ
Research organizations with strong capabilities in fibrosis biology, supporting target identification, validation, and translational assay development to de-risk discovery effortsÂ
Clinical CROs with Proven Competency in IPF & ILD TrialsÂ
Specialist CROs experienced in navigating rare lung disease trials, offering strategic input on study design, operational support for recruitment and site management, and expertise in meeting regulatory demandsÂ
Hear What Our Past Sponsors Have to Say
Varied programme and attended by several field experts
Great in-depth discussions about the challenges of drug development in the IPF space
Breadth of content covering everything happening in IPF and related diseases. Access to key people, and support to make intro's, in such a small area
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Finlay Coombes
Business Development Manager
CNS EventsÂ
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.